Copyright
©2007 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Feb 28, 2007; 13(8): 1149-1155
Published online Feb 28, 2007. doi: 10.3748/wjg.v13.i8.1149
Published online Feb 28, 2007. doi: 10.3748/wjg.v13.i8.1149
Practical guidelines for the treatment of inflammatory bowel disease
T Kuhbacher, UR Fölsch, Department of Internal Medicine, University Hospital Schleswig-Holstein, Campus Kiel, Schitten-helmstr.12, Kiel 24105, Germany
Author contributions: All authors contributed equally to the work.
Correspondence to: UR Fölsch, Department of Internal Medicine, University Hospital Schleswig-Holstein, Campus Kiel, Schittenhelmstr.12, 24105 Kiel, Germany. urföelsch@1med.uni-kiel.de
Telephone: +49-431-5971271 Fax: +49-431-5971271
Received: July 11, 2006
Revised: September 3, 2006
Accepted: December 28, 2006
Published online: February 28, 2007
Revised: September 3, 2006
Accepted: December 28, 2006
Published online: February 28, 2007
Abstract
In recent years, great progress has been made regarding the treatment of inflammatory bowel disease (IBD), particularly in the field of biological therapies. Nevertheless, the ultimate treatment is not in sight. With the development of new medication, it has become clear that we need a new understanding of IBD. Therapy needs to fit the different subtypes of IBD; e.g. mild disease in comparison to severe chronic active disease or Crohn's disease with or without fistulation or stenosis. The following article gives a practical overview of actual treatments for IBD. The intention of this article is not to provide a complete review of all new scientific developments, but to give a practical guideline for therapy of IBD.
Keywords: Inflammatory bowel disease, Ulcerative colitis, Crohn's disease, Immunomodulators, Anti-tumor necrosis factor